Med Aditus Pharmaceuticals, Inc.

RTP, NC · Founded 2023 · CIK 0002041640 · Biotech · Private

Continuous modular pharmaceutical manufacturing system with blockchain-based quality management

medadituspharmaceuticals.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$5.0M
1 Form D · Nov 2024
23 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3353INFINITE ENERGY LLC——
3354VANGUARD THERAPEUTICS, INC.——
3355enGene Holdings——
3356Med Aditus Pharmaceuticals, Inc.—$5.0M
3357CHRONUS PHARMACEUTICALS, INC.——
3358True North Therapeutics——
3359Neomorph——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Mary GunnDirector
  • Khama RogoDirector
  • David StefanichDirector
  • Dhiren ThakkerDirector · Executive Officer
  • Kay WagonerDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.